Majlessi; Laleh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Majlessi; Laleh.The latest application filed is for "recombinant mycobacterium bovis bcg expressing antigens of the mycobacterium marinum esx-1 secretion system".

Company Profile

0.6.9

Majlessi; Laleh - Montigny-le-Bretonneux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Mycobacterium bovis BCG expressing antigens of the Mycobacterium marinum ESX-1 secretion system Grant 10,010,597 - Brosch , et al. July 3, 2	2018-07-03
Recombinant Mycobacterium Bovis Bcg Expressing Antigens Of The Mycobacterium Marinum Esx-1 Secretion System App 20170106073 - BROSCH; Roland ; et al.	2017-04-20
Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti Grant 8,747,866 - Cole , et al. June 10, 2	2014-06-10
Streptavidin And Biotin-based Antigen Delivery System App 20130121958 - Leclerc; Claude ; et al.	2013-05-16
Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG Grant 8,398,991 - Brosch , et al. March 19, 2	2013-03-19
Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti App 20120189662 - Cole; Stewart ; et al.	2012-07-26
Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti Grant 7,883,712 - Cole , et al. February 8, 2	2011-02-08
Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20090317854 - Leclerc; Claude ; et al.	2009-12-24
Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG App 20070009547 - Brosch; Roland ; et al.	2007-01-11
Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20060286613 - Leclerc; Claude ; et al.	2006-12-21
Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20060019323 - Leclerc; Claude ; et al.	2006-01-26
Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti App 20050220811 - Cole, Stewart ; et al.	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.